Cargando…

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia

Hypogammaglobulinemia is the most frequently observed immune defect in chronic lymphocytic leukemia (CLL). Although CLL patients usually have low serum levels of all isotypes (IgG, IgM and IgA), standard immunoglobulin (Ig) preparations for replacement therapy administrated to these patients contain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colado, Ana, Elías, Esteban Enrique, Sarapura Martínez, Valeria Judith, Cordini, Gregorio, Morande, Pablo, Bezares, Fernando, Giordano, Mirta, Gamberale, Romina, Borge, Mercedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217488/ https://www.ncbi.nlm.nih.gov/pubmed/34155276 http://dx.doi.org/10.1038/s41598-021-92412-8

Ejemplares similares

Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia
por: Sarapura Martinez, Valeria J., et al.
Publicado: (2023)

In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia
por: Vereertbrugghen, Alexia, et al.
Publicado: (2021)

Revisiting the role of interleukin-8 in chronic lymphocytic leukemia
por: Risnik, Denise, et al.
Publicado: (2017)

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
por: Podaza, Enrique, et al.
Publicado: (2020)

Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis
por: Colado, Ana, et al.
Publicado: (2018)

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
por: Mimura, Yusuke, et al.
Publicado: (2022)

Erratum: Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
Publicado: (2022)

Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy?
por: López-Medrano, Francisco, et al.
Publicado: (2021)

The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives
por: Gargiulo, Ernesto, et al.
Publicado: (2023)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

IMMUNOGLOBULINS ON THE SURFACE OF LYMPHOCYTES : II. THE BONE MARROW AS THE MAIN SOURCE OF LYMPHOCYTES WITH DETECTABLE SURFACE-BOUND IMMUNOGLOBULIN
por: Unanue, Emil R., et al.
Publicado: (1971)

Intravenous Immunoglobulin Monotherapy for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency
por: Hasegawa, Mizue, et al.
Publicado: (2017)

Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease
por: Wu, Gang, et al.
Publicado: (2020)

Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia
por: Konovalova, Angelina, et al.
Publicado: (2023)

Peripherally induced Foxp3(+) regulatory T cells mediates the immunomodulatory effect of intravenous immunoglobulin in an experimental model of allergic airway disease
por: Massoud, Amir H, et al.
Publicado: (2014)

IMMUNOGLOBULINS ON THE SURFACE OF LYMPHOCYTES : I. DISTRIBUTION AND QUANTITATION
por: Rabellino, Enrique, et al.
Publicado: (1971)

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
por: Visentin, Andrea, et al.
Publicado: (2022)

Immunomodulatory activity accompanying chicken egg yolk immunoglobulin Y
por: Polanowski, A., et al.
Publicado: (2012)

Immunoglobulin Glycosylation – An Unexploited Potential for Immunomodulatory Strategies in Farm Animals
por: Zlatina, Kristina, et al.
Publicado: (2021)

Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report
por: Milani, Cannon, et al.
Publicado: (2009)

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
por: Pilon, Caroline, et al.
Publicado: (2020)

Exquisite response to intravenous immunoglobulin in Susac syndrome during pregnancy
por: Gomez-Figueroa, Enrique, et al.
Publicado: (2017)

Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection
por: Nakamura, Kensuke, et al.
Publicado: (2021)

Intravenous Immunoglobulin: Revisited – My Experience
por: Vaishampayan, Sanjeev S., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease
por: Chen, Yongbing, et al.
Publicado: (2019)

Immunomodulatory Effects of Cinobufagin on Murine Lymphocytes and Macrophages
por: Yu, Yang, et al.
Publicado: (2015)

Biosensors for Detecting Lymphocytes and Immunoglobulins
por: Salvo, Pietro, et al.
Publicado: (2020)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Intravenous Immunoglobulin Treatment in Multifocal Motor Neuropathy
por: van der Pol, W.-Ludo, et al.
Publicado: (2010)

Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
por: Orange, Jordan S., et al.
Publicado: (2013)

Intravenous immunoglobulin and Alzheimer’s disease: what now?
por: Loeffler, David A
Publicado: (2013)

541 Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency
por: Oropeza, Said Arablin, et al.
Publicado: (2012)

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
por: Jønch, Aia Elise, et al.
Publicado: (2012)

The Production Processes and Biological Effects of Intravenous Immunoglobulin
por: Barahona Afonso, Ana Filipa, et al.
Publicado: (2016)

Bilateral uveitis following intravenous immunoglobulin administration
por: Kocak, Enis D., et al.
Publicado: (2017)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ke7jmt3hn735f10ks0smvnd7c7